Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures FTSE +0.24%, DAX +0.20%, CAC40 +0.15%

Sep 16 ,2026

  • Synopsis

    • European equity futures point to a positive open. Follows Tuesday's weaker performance. Asian equity markets higher. Nikkei, Kospi and Taiex see modest outperformance. US equity futures higher with S&P up ~0.2%. US equities finished lower on Tuesday. Breadth was negative with S&P decliners more than double the gainers.

    • Markets waiting for key central bank policy decisions. Fed widely expected to raise interest rates by 25 bps later with rate expectations crystalized by August CPI. September odds now at ~90%. BoE set for steady hand on Thursday.

    • Early focus in Europe on UK inflation after soft labor market update on Tuesday. Other macro data on the agenda includes Eurozone industrial production, labor index and Eurozone wage growth data. Latter to provide snapshot of potential second round effects amid recent upward price on energy prices.

    • In central banks, Denmark central bank's Krogstrup speech at 10:00CET at the Eurofi Financial Forum in Ireland (through Fri), ECB's Vujčić chairs panel at 14:15CET at ECB Annual Research Conf 'Geoeconomics and the International Trading System' (through Thu) and ECB's Elderson speech at 15:00CET at Nature Finance and Resilience Day of Climate Finance Week Ireland (Mon-Thu). Also, Riksbank releases it's latest business survey at 9:30CET.

    • In politics, EU's von der Leyen delivers State of the Union address at 9:00CET. In the evening, Chancellor Merz hosts meeting of the Strategy Group for Technology and Innovation, with deliberations on strengthening the national AI ecosystem and the innovation potential in the defense sector on the agenda. Elsewhere, it's European Mobility Week (through Tue) and in Germany, BaFin Conf on Proportionality in Banking Supervision and Regulation as well as Big Bang AI Festival with Federal ministers Wildberger and Schneider as well as Chairman of the CSU Söder and Green Party Co-Chair Brantner, SAP (SAP.GR) Saueressig, others among the attendees/speakers at the latter

    • A light morning for earnings sees R&S Group Holding (RSGN.SW) reporting H1 results and SFS Group (SFSN.SW) reiterating its expectations for the current year. Elsewhere, Aeroport de Paris (ADP.FP) reported August traffic and GEK Terna (GEKTERNA.GA) reported H1 results.

  • Politics/Macro/World News

    • EU rebuffs Mark Carney's 'unique alliance' with Canada - FT

    • Ursula von der Leyen to give State of the Union speech - politico

    • French central bank trims growth outlook as demand softens - Reuters

  • Top company news

    • Earnings/updates

      • DACHs:

        • RSGN.SW (R&S Group Holding) -- reports H1 EPS CHF0.60 vs year-ago CHF0.77

        • SFSN.SW (SFS Group) -- reports expectations regarding SFS's business performance in the current year remain unchanged

      • France:

        • ADP.FP (Aeroport de Paris) -- reports Total Paris Aeroport August traffic 10.1M; (3.2%) y/y

      • Nordics:

        • BORR.NO (Borr Drilling) -- provides operational and contracting updates

      • Greece:

        • GEKTERNA.GA (GEK Terna) -- reports H1 net income €81.3M, +19% vs year-ago €68.3M

    • M&A

      • TRMD.A.DC (TORM) -- Hafnia to acquire 4.5M A shares in TORM plc at $32.25, representing 4.39% of outstanding share capital of TORM

      • MGN.NO (Magnora) -- subsidiary Magnora Data Center acquires 50% stake in joint venture to develop up to 400 MW data center in Risti

      • TFIN.IM (Trevi-Finanziaria Industriale) -- CONSOB approves Webuild's offer document in connection with the acquisition of Trevi-Finanziaria Industriale

      • TISG.IM (The Italian Sea Group) -- receives 11 non-binding offers relating to transactions structured as either asset deals or share deals

      • FFARM.NA (ForFarmers) -- to acquire 100% of the shares in STW SA

      • A3M.SM (ATRESMEDIA) -- Follow-up: ATRESMEDIA completes sale of its stake in FEVER; sees related gain of ~ €205M

      • VOD.LN (Vodafone Group) -- Vodafone may lose €1.1B in future earnings as result of Geodesia's sale of its 50% stake in OXG - FT

      • BAM (Brookfield Asset Management) -- Brookfield close to deal to recapitalize UK holiday park operator Center Parcs at a ~$6B valuation -- Bloomberg

      • GXI.GR (Gerresheimer) -- EU sets a provisional deadline of 20-Oct to rule on Apax Funds' acquisition of Gerresheimer's Centor US

      • SAFT (Safety Insurance Group) -- announces expiration of the Hart-Scott-Rodino waiting period for its proposed merger with Mapre - 8-K

      • DOKA.SW (dormakaba Holding) -- dormakaba to acquire Alliants Limited; terms not disclosed

      • RF.FP (Eurazeo) -- completes the acquisition of Netco Group

      • SHLTN.SW (SHL Telemedicine) -- paid additional NIS 2.6M (~ $0.8M) in indexation differentials and interest relating to the purchase price for stake in Mediton and Medishur, pursuant to court decision

    • Healthcare

      • ALCOX.FP (Nicox) -- to present key data on NCX 470 at AAOpt Annual Meeting 2026

      • GSK.LN (GSK Plc) -- Transcript Intelligence: GSK Plc at Morgan Stanley Global Healthcare Conference

      • MRK.GR (Merck KGaA) -- NICE recommends Merck KGaA's Ezmekly to treat symptomatic and inoperable plexiform neurofibromas associated with neurofibromatosis type 1 in people 2 to 17 years

      • LKFT.NA (Lakefront Biotherapeutics) -- Transcript Intelligence: Lakefront Biotherapeutics at Morgan Stanley Global Healthcare Conference

      • INDV (Indivior Pharmaceuticals) -- and Reckitt Benckiser Healthcare enter into Deed of Variation and Termination relating to their Copacker Supply agreement - 8-K

      • DBV.FP (DBV Technologies) -- Transcript Intelligence: DBV Technologies at H.C. Wainwright Global Investment Conference

      • BIM.FP (bioMerieux) -- receives IVDR Class D CE Marking for BIOFIRE Respiratory 2.1 plus Panel and BIOFIRE FILMARRAY Pneumonia plus Panel

      • IVA.FP (Inventiva) -- Transcript Intelligence: Inventiva at Morgan Stanley Global Healthcare Conference

    • Other

      • ALHYF.FP (Lhyfe) -- and H2APEX expand partnership to support growing demand for renewable hydrogen in Germany

      • ALSEN.FP (Sensorion) -- has confidentially submitted a draft registration statement on Form F-1 to the SEC

      • NDX1.GR (Nordex Group) -- receives 91 MW order from TEUT Energieprojekte in Brandenburg, Germany

      • TRE.SM (Tecnicas Reunidas) -- approves up to €50M share buyback program

      • AENA.SM (Aena) -- confirms Spanish government approved the Third Airport Regulation Document (DORA), which will be in force between 2027-31

      • GLEN.LN (Glencore) -- refers to reports in media regarding past business activities with Radiant World and associated companies

      • ASM.NA (ASM International) -- announces completion of €150M share buyback program

      • VK.FP (Vallourec) -- awarded major contract by Subsea7

      • CBK.GR (Commerzbank) -- Transcript Intelligence: Commerzbank at Barclays Global Financial Services Conference

      • ARCAD.NA (ARCADIS) -- launches Data Center Growth Lab to build next generation of data center talent

      • NDX1.GR (Nordex) -- Transcript Intelligence: Nordex at MWB Research Future of Energy Investor Conference

      • RENE.PL (Redes Energeticas Nacionais SGPS) -- publishes Gender Equality Plan 2027

      • Caturus announces 7.75 Mtpa expansion project for Commonwealth LNG

      • Indivior Pharmaceuticals and Reckitt Benckiser Healthcare enter into Deed of Variation and Termination relating to their Copacker Supply agreement - 8-K

  • Key rating changes

    • Upgrades

      • Berenberg upgrades BMW.GR; downgrades STLAM.IM

      • Deutsche Bank upgrades ABI.BB, CPR.IM

      • AENA.SM (Aena S.M.E.) -- to hold from sell at Deutsche Bank

      • AMS.SM (Amadeus IT Group) -- to buy from hold at Deutsche Bank

      • SOI.FP (SOITEC) -- to overweight from neutral at JPMorgan

    • Downgrades

      • ABF.LN (Associated British Foods) -- hold from buy at Kepler Cheuvreux

      • SAB.SM (Banco de Sabadell) -- hold from buy at Bestinver Securities

      • HEM.SS (Hemnet Group) -- to hold from buy at DNB Carnegie

      • COLR.BB (Colruyt Group) -- to neutral from outperform at Oddo

      • SAFE.LN (Safestore Holdings) -- to neutral from outperform at Oddo

    • Initiations

      • KBC.BB (KBC Group) -- buy at Jefferies

      • SIGN.SW (SIG Combibloc Group) -- neutral at JPMorgan

    • Other Actions

      • NHY.NO (Norsk Hydro) -- transferred, downgraded to sector perform from outperform at RBC Capital Markets

      • BAMI.IM (Banco BPM) -- resumed neutral at JPMorgan; prior rating was neutral

  • Data

    • Nikkei +0.40% to 63736.95

    • Hang Seng +0.09% to 24688.37

    • Shanghai Composite +0.58% to 3886.87

    • S&P futures +16.0 vs prior close of 7656.0

    • €-$ +0.0010 or +0.09% to 1.1553

    • $-¥ +0.08 or +0.05% to 155.18

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.